Literature DB >> 9098648

Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder.

B A Alman1, M E Pajerski, S Diaz-Cano, K Corboy, H J Wolfe.   

Abstract

Aggressive fibromatosis (also called deep fibromatosis or desmoid tumor) is a proliferation of cytologically benign-appearing fibrocytes, often resulting in significant functional loss. The nature of the lesion is controversial: some evidence suggests that it is a reactive process, whereas other evidence supports a neoplastic etiology. The pattern of X chromosome inactivation, using a technique based on polymerase chain reaction (PCR) amplification of a hypervariable CAG repeat region flanking Hhal restriction sites of the human androgen receptor gene, was determined in four cases in which cryopreserved tumor and adjacent normal tissue were available. All four tumors demonstrated a monoclonal pattern, while the adjacent normal tissues demonstrated a polyclonal pattern. This demonstrates that aggressive fibromatosis is proliferation of cells derived from a single clone with a growth advantage, and thus is likely a neoplastic process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098648     DOI: 10.1097/00019606-199704000-00005

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  37 in total

1.  Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).

Authors:  B A Alman; C Li; M E Pajerski; S Diaz-Cano; H J Wolfe
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Recurrence patterns and management options in aggressive fibromatosis.

Authors:  Rajaraman Ramamurthy; Balasubramanian Arumugam; Balasubramaniam Ramanandham
Journal:  Indian J Surg Oncol       Date:  2012-05-12

3.  Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.

Authors:  Aimee M Crago; Juliann Chmielecki; Mara Rosenberg; Rachael O'Connor; Caitlin Byrne; Fatima G Wilder; Katherine Thorn; Phaedra Agius; Deborah Kuk; Nicholas D Socci; Li-Xuan Qin; Matthew Meyerson; Meera Hameed; Samuel Singer
Journal:  Genes Chromosomes Cancer       Date:  2015-07-14       Impact factor: 5.006

4.  [Huge retrovesical tumor as an incidental finding: desmoid-type fibromatosis: a case report].

Authors:  T Franz; T Häfner; L C Horn; W Kassahun; J-U Stolzenburg
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

5.  Gigantic recurrent abdominal desmoid tumour: a case report.

Authors:  E A Rakha; M A Kandil; M G El-Santawe
Journal:  Hernia       Date:  2006-12-06       Impact factor: 4.739

6.  MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours.

Authors:  Firouzeh Kamali; Wei-Lien Wang; B A Guadagnolo; Patricia S Fox; Valerae O Lewis; Alexander J Lazar; Anthony P Conley; Vinod Ravi; Mohammad Toliyat; Harshad S Ladha; Brian P Hobbs; Behrang Amini
Journal:  Br J Radiol       Date:  2015-11-18       Impact factor: 3.039

7.  A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis.

Authors:  Jean-Emmanuel Kurtz; Irène Asmane; Anne-Claire Voegeli; Agnès Neuville; Armelle Dufresne; Valère Litique; Christine Chevreau; Jean-Pierre Bergerat
Journal:  Sarcoma       Date:  2010-03-17

8.  A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.

Authors:  Jae-Cheol Jo; Yong Sang Hong; Kyu-Pyo Kim; Jae-Lyun Lee; Jeeyun Lee; Young Suk Park; Sun Young Kim; Jin-Sook Ryu; Jong-Seok Lee; Tae Won Kim
Journal:  Invest New Drugs       Date:  2014-01-16       Impact factor: 3.850

Review 9.  Updates on abdominal desmoid tumors.

Authors:  Bernardino Rampone; Corrado Pedrazzani; Daniele Marrelli; Enrico Pinto; Franco Roviello
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

10.  β-Catenin mutation status and outcomes in sporadic desmoid tumors.

Authors:  John T Mullen; Thomas F DeLaney; Andrew E Rosenberg; Long Le; A John Iafrate; Wendy Kobayashi; Jackie Szymonifka; Beow Y Yeap; Yen-Lin Chen; David C Harmon; Edwin Choy; Sam S Yoon; Kevin A Raskin; Francis J Hornicek; Gunnlauger P Nielsen
Journal:  Oncologist       Date:  2013-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.